share_log

藥明生物：董事會會議日期

WUXI BIO: DATE OF BOARD MEETING

Hong Kong Stock Exchange ·  Jul 25 16:30
Summary by Futu AI
药明生物技术有限公司宣布，將於2024年8月21日（星期三）在香港召開董事會會議。會議的主要議程為考慮及通過集團截至2024年6月30日止六個月的中期業績及其刊發。該公司及其附屬公司統稱為本集團，而董事會成員包括執行董事陳智勝博士，非執行董事李革博士、周偉昌博士、吳亦兵博士及曹彥凌先生，以及獨立非執行董事William Robert Keller先生、Kenneth Walton Hitchner III先生、戴國良先生及陳珏博士。
药明生物技术有限公司宣布，將於2024年8月21日（星期三）在香港召開董事會會議。會議的主要議程為考慮及通過集團截至2024年6月30日止六個月的中期業績及其刊發。該公司及其附屬公司統稱為本集團，而董事會成員包括執行董事陳智勝博士，非執行董事李革博士、周偉昌博士、吳亦兵博士及曹彥凌先生，以及獨立非執行董事William Robert Keller先生、Kenneth Walton Hitchner III先生、戴國良先生及陳珏博士。
WuXi Biologics announced that it will hold a board of directors meeting in Hong Kong on Wednesday, August 21, 2024. The main agenda of the meeting is to consider and pass the group's interim performance ending on June 30, 2024 and its publication. The company and its subsidiaries are collectively called this group, and the board of directors includes executive director Dr. Chen Zhisheng, non-executive directors Dr. Li Ge, Dr. Zhou Weichang, Dr. Wu Yibing and Mr. Cao Yanling, as well as independent non-executive directors Mr. William Robert Keller, Mr. Kenneth Walton Hitchner III, Mr. Dai Guoliang and Dr. Chen Jue.
WuXi Biologics announced that it will hold a board of directors meeting in Hong Kong on Wednesday, August 21, 2024. The main agenda of the meeting is to consider and pass the group's interim performance ending on June 30, 2024 and its publication. The company and its subsidiaries are collectively called this group, and the board of directors includes executive director Dr. Chen Zhisheng, non-executive directors Dr. Li Ge, Dr. Zhou Weichang, Dr. Wu Yibing and Mr. Cao Yanling, as well as independent non-executive directors Mr. William Robert Keller, Mr. Kenneth Walton Hitchner III, Mr. Dai Guoliang and Dr. Chen Jue.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.